General Statement of Disclosure:

CONSULTING FEES/HONORARIA: Esperion(SIGNIFICANT) SPEAKER'S BUREAU: Amarin(SIGNIFICANT), Amgen(SIGNIFICANT), Boehringer Ingelheim Pharmaceuticals, Inc(SIGNIFICANT), AstraZeneca Pharmaceuticals(SIGNIFICANT), Novo Nordisk Inc.(SIGNIFICANT) RESEARCH/RESEARCH GRANTS: General Electric(SIGNIFICANT)

View Full Disclosure